Q&A: Slalom’s senior experts in life sciences and healthcare shine a spotlight on the future of these deeply intertwined industries.
Amy Loftus, general manager of Slalom’s Philadelphia office, has been working in life sciences as a consultant and executive for over 25 years. And Emily Borlik, managing director of Slalom’s cross-market healthcare practice, has been a healthcare consultant for nearly 20 years. Together, this cross-industry dream team will host a Slalom webinar on March 21, Bracing for disruption: Building agility in life sciences and healthcare. In anticipation, we asked Loftus and Borlik to offer a big picture perspective on the current and future state of their respective industries.
What are you hearing most from your clients right now? What are their top-of-mind challenges?
Loftus: In the life sciences, increasing regulatory and pricing pressures are a big challenge, as is the ever-greater need to drive collaboration and novel partnerships both within and outside of the life sciences community. Many organizations are working on their ability to absorb new data and quickly apply it to their business. There’s also an increasing need and pressure to provide more support to patients on their journeys toward health and disease management.
Borlik: Meeting the Triple Aim is still paramount for healthcare leaders. We need to continue to find ways to create value and improve outcomes at a lower cost. Healthcare leaders recognize that their patients or members are actually consumers. We’re all trying to get closer to them to understand the 360-view of the patient—meaning not just their health, but also their needs and preferences. There’s significant information trapped within our systems and interactions at the clinical level, but how do we surface that in a secure and usable way? Finally, we need to address “access and continuum of care,” particularly our relationships with our clinicians and finding new ways and technologies to do more with less.
What do you see on the horizon that leaders in life sciences and healthcare need to be thinking about more?
Loftus: There continues to be a need to bring together the various stakeholders across healthcare and life sciences to better improve outcomes for patients. Often stakeholders are looking at complex problems through a single lens. For example, they may be considering how to better support patients, but not considering how providers are included in the equation or how payers may have reimbursement challenges.